The epigenetic reactivation of EphA7 via dCas9-TET1 reduced tumor growth and enhanced sensitivity to chemo-, radio- and immunotherapy by modulating SP1/DNMT1 and PI3K/AKT signalling. Here, SP1 is linked to neoplasm.